Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Anatomy (1)
- Anesthesia and Analgesia (1)
- Behavioral Neurobiology (1)
- Chemical Actions and Uses (1)
-
- Chemical and Pharmacologic Phenomena (1)
- Clinical and Medical Social Work (1)
- Cognitive Behavioral Therapy (1)
- Community Health (1)
- Community Health and Preventive Medicine (1)
- Complex Mixtures (1)
- Emergency Medicine (1)
- Family Medicine (1)
- Health Policy (1)
- Internal Medicine (1)
- Life Sciences (1)
- Medical Pharmacology (1)
- Medical Sciences (1)
- Medical Specialties (1)
- Medical Toxicology (1)
- Mental and Social Health (1)
- Molecular and Cellular Neuroscience (1)
- Neuroscience and Neurobiology (1)
- Oncology (1)
- Other Medical Sciences (1)
- Other Pharmacology, Toxicology and Environmental Health (1)
- Other Physiology (1)
- Keyword
- File Type
Articles 1 - 2 of 2
Full-Text Articles in Other Chemicals and Drugs
Opioid Use Disorder: The Timeline For Medication Assisted Therapy, Alexander Cristofori
Opioid Use Disorder: The Timeline For Medication Assisted Therapy, Alexander Cristofori
Capstone Showcase
Opioid Use Disorder is patterns of opioid use leading to withdrawal, giving up important life events in order to use opioids, and excessive time spent using opioids, to name a few diagnostic criteria. The clinical progression of the disorder involves periods of acute exacerbation and remission that are cyclic in nature. Treatment is most effective when it includes both pharmacological and psychosocial modalities, referred to as medication assisted therapy (MAT). Three drugs used commonly in MAT-based treatment for OUD from oldest to newest include Methadone, Buprenorphine-naloxone, and Naltrexone. Treatment program models that prioritize total abstinence from the addictive substance attached …
Alternatives To Red Blood Cell Transfusions, Julia Prosser
Alternatives To Red Blood Cell Transfusions, Julia Prosser
Capstone Showcase
Abstract
Introduction: Allogenic red blood cell (RBC) transfusions are used for a number of different reasons. As with any medical procedure, allogenic RBC transfusions are not risk-free. Since the first recorded blood transfusion in 1655, the process has remained relatively unchanged. ABO incompatibility and contamination with infectious diseases are two major complications associated with RBC transfusions. Furthermore, traditional allogenic RBC transfusions have supply and demand issues. These issues, plus several more, could be alleviated with the use of artificial blood. This paper addresses the important clinical question: In patients who require RBC transfusions (P), is there a viable artificial blood …